{
  "first_published_at": "2007-10-01", 
  "original_url": "http://www.mhra.gov.uk/Safetyinformation/DrugSafetyUpdate/CON079225", 
  "title": "Lorazepam: reduction of recommended maximum daily dose", 
  "tags": "{\"parsed_therapeutic\": [\"psychiatry\"], \"Audience:\": [\"Primary care\", \"Secondary care\"], \"Therapeutic area:\": [\"Psychiatry\"]}", 
  "_document_number": 317, 
  "label": null, 
  "icon": "http://www.mhra.gov.uk/home/images/MHRALook/img/dsu/change_icon.png", 
  "therapeutic_area": [
    "psychiatry"
  ], 
  "raw_html": "<div id=\"dsuArticleContent\">\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t\t<h1><a name=\"maincontent\" id=\"maincontent\"></a>Lorazepam: reduction of recommended maximum daily dose</h1>\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t<span class=\"ref\">Article date: October 2007</span> \r\n\t\t\t\t\t\t\t\t<!--SS_BEGIN_ELEMENT(region1_element21)-->\r\n\t\t\t\t\t\t\t\t<!---->\r\n\t\t\t\t\t\t\t\t<!--SS_END_ELEMENT(region1_element21)-->\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t<!--SS_BEGIN_ELEMENT(region1_element22)-->\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t<!--SS_END_ELEMENT(region1_element22)-->\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t<div id=\"dsuSynopsis\" class=\"yellow\">\r\n\t\t\t\t\t\t\t\t\t<div class=\"dsuArticlePadding\">\r\n\t\t\t\t\t\t\t\t\t<span id=\"dsuSynopsisTitle\"><b>Summary</b></span>\t\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t\t<br>Maximum dose of lorazepam for short term, symptomatic treatment is 4 mg per day for severe, disabling anxiety, and 2 mg per day for severe, disabling insomnia<br>\t\r\n\t\t\t\t\t\t\t\t\t</div>         \t\t\r\n\t\t\t\t\t\t\t\t\t<div id=\"dsuSynopsisCut\">\r\n\t\t\t\t\t\t\t\t\t</div>\r\n\t\t\t\t\t\t\t\t</div>\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t<!--SS_BEGIN_ELEMENT(region1_element13)-->\r\n\t\t\t\t\t\t\t\t<!--<p>Lorazepam is a benzodiazepine anxiolytic; its indications include short-term use in anxiety or insomnia.</p><p>Prescribers are reminded of previous advice:</p><ul>\r\n\t\t\t<li>Benzodiazepines are indicated for the short-term relief (2&ndash;4 weeks only) of anxiety that is severe, disabling, or subjecting the individual to unacceptable distress, occurring alone or in association with insomnia or short-term psychosomatic, organic, or psychotic illness</li>\r\n\t\t\t<li>The use of benzodiazepines to treat short-term mild anxiety is inappropriate and unsuitable</li>\r\n\t\t\t<li>Benzodiazepines should be used to treat insomnia only when it is severe, disabling, or subjecting the individual to extreme distress</li></ul><p>Doses of lorazepam above 4 mg per day are not considered appropriate in view of the recommended maximum treatment duration of 4 weeks, which includes a dose-reduction period. Prescribing information, which previously contained posology for up to 10 mg per day for lorazepam (equivalent to 100 mg per day of diazepam), is being updated for relevant products.</p><div class=\"dull_highlight\">\r\n\t\t\t<p><strong>Advice for healthcare professionals:</strong></p>\r\n\t\t\t<ul>\r\n\t\t\t\t<li>The maximum dose of lorazepam is 4 mg per day for the short-term treatment of anxiety and phobia, and is 2 mg per day for the treatment of insomnia</li>\r\n\t\t\t</ul></div><p>See also <a href=\"http://bnf.org/bnf/\" target=\"_blank\">British National Formulary</a> for information about lorazepam dosing.</p><p>&nbsp;</p><p><em>Article citation: Drug Safety Update October 2007; Vol 1, Issue 3: 8.</em></p>-->\r\n\t\t\t\t\t\t\t\t<!--SS_END_ELEMENT(region1_element13)-->\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t<!-- SS_BEGIN_SNIPPET(fragment7,1)-->\r\n\t\t\t\t\t\t\t\t<!-- call include to dynamically insert alt attributes into image tags within a wysiwyg element -->\r\n<!-- get a reference to the wysiwyg content -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n\t<p>Lorazepam is a benzodiazepine anxiolytic; its indications include short-term use in anxiety or insomnia.</p><p>Prescribers are reminded of previous advice:</p><ul>\r\n\t\t\t<li>Benzodiazepines are indicated for the short-term relief (2&#8211;4 weeks only) of anxiety that is severe, disabling, or subjecting the individual to unacceptable distress, occurring alone or in association with insomnia or short-term psychosomatic, organic, or psychotic illness</li>\r\n\t\t\t<li>The use of benzodiazepines to treat short-term mild anxiety is inappropriate and unsuitable</li>\r\n\t\t\t<li>Benzodiazepines should be used to treat insomnia only when it is severe, disabling, or subjecting the individual to extreme distress</li></ul><p>Doses of lorazepam above 4 mg per day are not considered appropriate in view of the recommended maximum treatment duration of 4 weeks, which includes a dose-reduction period. Prescribing information, which previously contained posology for up to 10 mg per day for lorazepam (equivalent to 100 mg per day of diazepam), is being updated for relevant products.</p><div class=\"dull_highlight\">\r\n\t\t\t<p><strong>Advice for healthcare professionals:</strong></p>\r\n\t\t\t<ul>\r\n\t\t\t\t<li>The maximum dose of lorazepam is 4 mg per day for the short-term treatment of anxiety and phobia, and is 2 mg per day for the treatment of insomnia</li>\r\n\t\t\t</ul></div><p>See also <a href=\"http://bnf.org/bnf/\" target=\"_blank\">British National Formulary</a> for information about lorazepam dosing.</p><p>&#160;</p><p><em>Article citation: Drug Safety Update October 2007; Vol 1, Issue 3: 8.</em></p>\r\n\t\t\t\r\n\t\t\t\t\t\t\t\t<!-- SS_END_SNIPPET(fragment7,1)-->\r\n\t\t\t\t\t\t\t</div>\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t", 
  "date_of_article": "2007-10-01", 
  "date_last_modified": "2010-08-23", 
  "_assets": [], 
  "_item_id": 317, 
  "summary": "Maximum dose of lorazepam for short term, symptomatic treatment is 4 mg per day for severe, disabling anxiety, and 2 mg per day for severe, disabling insomnia", 
  "body": "Article date: October 2007\n\nLorazepam is a benzodiazepine anxiolytic; its indications include short-term use in anxiety or insomnia.\n\nPrescribers are reminded of previous advice:  \n  \n  * Benzodiazepines are indicated for the short-term relief (2–4 weeks only) of anxiety that is severe, disabling, or subjecting the individual to unacceptable distress, occurring alone or in association with insomnia or short-term psychosomatic, organic, or psychotic illness  \n  * The use of benzodiazepines to treat short-term mild anxiety is inappropriate and unsuitable  \n  * Benzodiazepines should be used to treat insomnia only when it is severe, disabling, or subjecting the individual to extreme distress  \n  \nDoses of lorazepam above 4 mg per day are not considered appropriate in view of the recommended maximum treatment duration of 4 weeks, which includes a dose-reduction period. Prescribing information, which previously contained posology for up to 10 mg per day for lorazepam (equivalent to 100 mg per day of diazepam), is being updated for relevant products.\n\nAdvice for healthcare professionals:  \n  \n  * The maximum dose of lorazepam is 4 mg per day for the short-term treatment of anxiety and phobia, and is 2 mg per day for the treatment of insomnia  \n  \nSee also [British National Formulary](http://bnf.org/bnf/) for information about lorazepam dosing.\n\n \n\nArticle citation: Drug Safety Update October 2007; Vol 1, Issue 3: 8.\n"
}